These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33605620)

  • 21. Efficacy and safety of adjunctive nebulized colistin sulfate for multidrug-resistant Gram-negative bacteria pneumonia: a retrospective comparative cohort study.
    Bao XL; Tao T; Tang N; Wang YZ; Liao XQ; Huang LL; Ji JJ; Chen X
    Ann Palliat Med; 2022 Sep; 11(9):2939-2951. PubMed ID: 36217623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nebulization of Antiinfective Agents in Invasively Mechanically Ventilated Adults: A Systematic Review and Meta-analysis.
    Solé-Lleonart C; Rouby JJ; Blot S; Poulakou G; Chastre J; Palmer LB; Bassetti M; Luyt CE; Pereira JM; Riera J; Felton T; Dhanani J; Welte T; Garcia-Alamino JM; Roberts JA; Rello J
    Anesthesiology; 2017 May; 126(5):890-908. PubMed ID: 28248714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled antibiotics for the treatment of pneumonia.
    Schreiber MP; Shorr AF
    Curr Opin Pulm Med; 2019 May; 25(3):289-293. PubMed ID: 30562188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized control study of nebulized colistin as an adjunctive therapy in ventilator-associated pneumonia in pediatric postoperative cardiac surgical population.
    Bharathi KS; Bhat A; Pruthi G; Simha PP
    Ann Card Anaesth; 2022; 25(4):435-440. PubMed ID: 36254907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolized amikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients.
    Montgomery AB; Vallance S; Abuan T; Tservistas M; Davies A
    J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):441-8. PubMed ID: 24383962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients.
    Rello J; Rouby JJ; Sole-Lleonart C; Chastre J; Blot S; Luyt CE; Riera J; Vos MC; Monsel A; Dhanani J; Roberts JA
    Clin Microbiol Infect; 2017 Sep; 23(9):640-646. PubMed ID: 28347790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebulized Amikacin and Fosfomycin for Severe Pseudomonas aeruginosa Pneumonia: An Experimental Study.
    Li Bassi G; Motos A; Fernandez-Barat L; Aguilera Xiol E; Chiurazzi C; Senussi T; Saco MA; Fuster C; Carbonara M; Bobi J; Amaro R; De Rosa F; Comaru T; Yang H; Ranzani OT; Marti JD; Rinaudo M; Comino Trinidad O; Rigol M; Bringué J; Ramirez J; Nicolau DP; Pelosi P; Antonelli M; Blasi F; Artigas A; Montgomery AB; Torres A
    Crit Care Med; 2019 Jun; 47(6):e470-e477. PubMed ID: 30882478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic review.
    Russell CJ; Shiroishi MS; Siantz E; Wu BW; Patino CM
    BMC Pulm Med; 2016 Mar; 16():40. PubMed ID: 26956371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance.
    Ghannam DE; Rodriguez GH; Raad II; Safdar A
    Eur J Clin Microbiol Infect Dis; 2009 Mar; 28(3):253-9. PubMed ID: 18752007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of nebulized antimicrobial agents in burned and mechanically ventilated patients with persistent Acinetobacter baumannii, Pseudomonas aeruginosa, or Enterobacteriacea.
    Ackerman BH; Reigart CL; Stair-Buchmann M; Haith LR; Patton ML; Guilday RE
    Burns; 2013 Aug; 39(5):885-91. PubMed ID: 23195712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nebulized colistin for treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: we still need to straighten out the dose!
    Honore PM; Jacobs R; Hendrickx I; De Waele E; De Regt J; Spapen HD
    Crit Care; 2015 Jun; 19(1):265. PubMed ID: 26113262
    [No Abstract]   [Full Text] [Related]  

  • 32. Prophylactic Antibiotics Delivered Via the Respiratory Tract to Reduce Ventilator-Associated Pneumonia: A Systematic Review, Network Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials.
    Li J; Lyu S; Luo J; Liu P; Albuainain FA; Alamoudi OA; Rochette V; Ehrmann S
    Crit Care Med; 2024 Oct; 52(10):1612-1623. PubMed ID: 38722206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Update on Aerosolized Antibiotics for Treating Hospital-Acquired and Ventilator-Associated Pneumonia in Adults.
    Wood GC; Swanson JM
    Ann Pharmacother; 2017 Dec; 51(12):1112-1121. PubMed ID: 28778127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of adjunctive inhaled colistin and tobramycin for ventilator-associated pneumonia: systematic review and meta-analysis.
    Buendía JA; Guerrero Patiño D; Zuluaga Salazar AF
    BMC Pulm Med; 2024 May; 24(1):213. PubMed ID: 38698403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia - a matched case-control study in neonates.
    Hussain K; Salat MS; Ambreen G; Mughal A; Idrees S; Sohail M; Iqbal J
    Expert Opin Drug Saf; 2020 Dec; 19(12):1641-1649. PubMed ID: 32892635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective.
    Giacobbe DR; Roberts JA; Abdul-Aziz MH; de Montmollin E; Timsit JF; Bassetti M
    Expert Rev Anti Infect Ther; 2022 Jul; 20(7):963-979. PubMed ID: 35385681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia.
    Mohr AM; Sifri ZC; Horng HS; Sadek R; Savetamal A; Hauser CJ; Livingston DH
    Surg Infect (Larchmt); 2007 Jun; 8(3):349-57. PubMed ID: 17635058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nebulized antibiotics in mechanically ventilated patients: a challenge for translational research from technology to clinical care.
    Ehrmann S; Chastre J; Diot P; Lu Q
    Ann Intensive Care; 2017 Dec; 7(1):78. PubMed ID: 28766281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.